- Home
- / Genocea Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Genocea Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2023-02-23
Market Capitalization
$5.7 K
2023-02-23
Revenue
$1.6 M
FY, 2021
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.4M | 1.6M | ||||||
| General and administrative expense | 9.7M | 14.0M | 15.4M | 13.4M | 14.3M | 12.0M | 14.4M | 14.7M |
| Operating expense total | 33.5M | 42.0M | 50.1M | 52.6M | 39.5M | 39.0M | 48.3M | |
| EBIT | (33.2M) | (41.4M) | (48.2M) | (55.3M) | (39.5M) | (39.0M) | (47.0M) | |
| EBIT margin, % | -3457.6% | |||||||
| Interest income | 410.0K | 250.0K | ||||||
| Interest expense | 970.0K | 1.1M | 1.3M | 1.5M | 11.7M | 39.0K | ||
| Net Income | (35.3M) | (42.5M) | (49.6M) | (56.7M) | (27.8M) | (38.9M) | (43.7M) | (33.2M) |